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With this special issue on chlamydial infections, our intention
is that non-specialist readers will be exposed to the many
aspects of chlamydiology, including epidemiology, taxonomy,
biodiversity, evolution, diagnosis and treatment, and hopefully
that even specialists will appreciate this overview of the
pathogenesis of chlamydial infections.
Chlamydia trachomatis is the most common bacterial cause
of urogenital infections. As described in the review by
Be´be´ar and de Barbeyrac, this strictly intracellular pathogenic
bacterium frequently causes an asymptomatic or paucisymp-
tomatic infection that remains undetected and thus untreated
for a prolonged period. From an evolutionary perspective,
this is favourable for the pathogen, as untreated chronic
infections may spread. The chronic inﬂammation then results
in long-term complications such as tubal infertility and
increased risk of extra-uterine pregnancy. To reduce this
morbidity and to reduce transmission, large routine screen-
ing programmes have been initiated. However, some strains
of C. trachomatis have lost a DNA region that is targeted by
frequently used PCRs. This example of rapid counter-evolu-
tion, called ‘the Swedish mutant paradigm’, occurred incred-
ibly early after the introduction of these molecular tests into
screening programmes. It shows that Chlamydia spp. may
evolve rapidly, despite being intracellularly located and
despite exhibiting a highly conserved core genome. It also
shows the importance of such a strict intracellular bacterium
remaining unrecognized. This example of rapid counter-evo-
lution should encourage clinical microbiologists to use a
panel of diagnostic tools and/or to develop tests that include
several simultaneous targets for this pathogen.
Like C. trachomatis, Chlamydia psittaci may also remain
undetected in clinical practice, as this strictly intracellular
bacterium does not grow on the media used routinely in
clinical diagnostic laboratories. However, in contrast to the
frequently chronic and paucisymptomatic C. trachomatis infec-
tions, pneumonia caused by C. psittaci may be acute, severe
and life-threatening. The identiﬁcation of C. psittaci infections
is important in order to guide public health prevention mea-
sures and to guarantee an adequate and targeted antibiotic
therapy. In their review, Beeckman et al. highlight the zoono-
tic potential of this pathogen and propose clues for diagnosis
and therapy of C. psittaci infections.
Parachlamydia acanthamoebae is another strictly intracellu-
lar bacterium, belonging to the order Chlamydiales. It easily
grows within free-living amoebae (Fig. 1). It represents an
emerging agent of community-acquired pneumonia and
bronchiolitis. My own contribution to this special issue on
chlamydial infections reviews the current knowledge accumu-
lated during the last 10 years concerning this Chlamydia-
related bacterium. Like that of C. psittaci, the pathogenic role
of P. acanthamoebae in humans was initially suspected follow-
ing an outbreak. Moreover, like C. psittaci, P. acanthamoebae
might be zoonotically transmitted. It may also, like Legionella
pneumophila, be transmitted through exposure to aerosols,
as free-living amoebae—its natural hosts—are largely present
in water. This review on P. acanthamoebae is not only
addressed to microbiologists interested in this evolutionarily
distant member of the Chlamydiales, but also proposes a
strategy to determine the pathogenic role of any new bacter-
ial species.
FIG. 1. Parachlamydia acanthamoebae strain Hall’s coccus within
Acanthamoebae castellanii. The cell wall of P. acanthamoebae (in green)
was stained with mouse anti-Parachlamydia antibodies, whereas its
DNA was stained with 4¢,6-diamidino-2-phenylindole (DAPI). The
amoeba was stained with concavalin A. Confocal microscopy, 1000·
magniﬁcation.
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Like C. psittaci and P. acanthamoebae, Chlamydia pneumoniae
mainly causes lower respiratory tract infections. In their
review, Blasi et al. summarize the main diagnostic approaches
to C. pneumoniae infections. Although serology is still largely
used to diagnose C. pneumoniae infections, molecular tools are
increasingly being used for the diagnosis of this chlamydial
infection. In addition to its role as an agent of respiratory tract
infections, C. pneumoniae might also be involved in other dis-
eases, e.g. arteriosclerosis. Although its role in this setting
remains controversial, the possible underlying pathogenic
mechanisms have been studied in detail. The review by Kern
et al. presents the recent advances of basic research in under-
standing the pathogenesis of C. pneumoniae infections. As with
all other members of the Chlamydiales, the strictly intracellular
nature of C. pneumoniae makes the research more complex,
i.e. by preventing direct assessment of the role of bacterial fac-
tors through forward genetics and by necessitating speciﬁc
skills to grow and isolate these bacteria. Despite the difﬁculties
faced by chlamydiologists, the many recent advances illustrate
the dynamic nature of the current research in this area.
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